Commercialized kit to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in Health Care Workers
Mónica Martínez-Gallo, Juliana Esperalba-Esquerra, Ricardo Pujol-Borrell, Víctor Sandá, Iria Arrese-Muñoz, Candela Fernández-Naval, Andrés Antón-Pagarolas, Victoria Cardona, View ORCID ProfileMoisés Labrador-Horrillo, Tomás Pumarola-Suñé, Manuel Hernandéz-González
doi: https://doi.org/10.1101/2021.03.31.21254472
Mónica Martínez-Gallo
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
2Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
3Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
Juliana Esperalba-Esquerra
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
Ricardo Pujol-Borrell
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
2Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
3Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
Víctor Sandá
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
Iria Arrese-Muñoz
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
Candela Fernández-Naval
5Microbiology Department, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
9Medicine Department. Universitat Autònoma de Barcelona (UAB). Barcelona. Spain
Andrés Antón-Pagarolas
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
Victoria Cardona
6Allergy Section, Internal Medicine Department. Hospital Universitari Vall d’Hebron (HUVH). Barcelona, Catalonia, Spain
7ARADyAL research network. Instituto de Salud Carlos III (ISCIII). Spain
8Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
9Medicine Department. Universitat Autònoma de Barcelona (UAB). Barcelona. Spain
Moisés Labrador-Horrillo
6Allergy Section, Internal Medicine Department. Hospital Universitari Vall d’Hebron (HUVH). Barcelona, Catalonia, Spain
7ARADyAL research network. Instituto de Salud Carlos III (ISCIII). Spain
8Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
9Medicine Department. Universitat Autònoma de Barcelona (UAB). Barcelona. Spain
Tomás Pumarola-Suñé
4Microbiology Division, Hospital Universitari Vall d’Hebron (HUVH). Departament de Genètica i Microbiologia. Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
Manuel Hernandéz-González
1Immunology Division, Hospital Universitari Vall d’Hebron (HUVH), Jeffrey Model Foundation Excellence Center. Barcelona, Catalonia, Spain
2Diagnostic Immunology research group Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
3Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB). Barcelona, Catalonia, Spain
Data Availability
27-March-2021
Posted July 08, 2021.
Commercialized kit to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in Health Care Workers
Mónica Martínez-Gallo, Juliana Esperalba-Esquerra, Ricardo Pujol-Borrell, Víctor Sandá, Iria Arrese-Muñoz, Candela Fernández-Naval, Andrés Antón-Pagarolas, Victoria Cardona, Moisés Labrador-Horrillo, Tomás Pumarola-Suñé, Manuel Hernandéz-González
medRxiv 2021.03.31.21254472; doi: https://doi.org/10.1101/2021.03.31.21254472
Commercialized kit to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in Health Care Workers
Mónica Martínez-Gallo, Juliana Esperalba-Esquerra, Ricardo Pujol-Borrell, Víctor Sandá, Iria Arrese-Muñoz, Candela Fernández-Naval, Andrés Antón-Pagarolas, Victoria Cardona, Moisés Labrador-Horrillo, Tomás Pumarola-Suñé, Manuel Hernandéz-González
medRxiv 2021.03.31.21254472; doi: https://doi.org/10.1101/2021.03.31.21254472
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (624)
- Anesthesia (162)
- Cardiovascular Medicine (2335)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11700)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3686)
- Geriatric Medicine (345)
- Health Economics (632)
- Health Informatics (2364)
- Health Policy (925)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3449)
- Nursing (194)
- Nutrition (520)
- Oncology (1801)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (285)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6090)
- Radiology and Imaging (1256)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)